• Acquires 23.5% strategic equity stake in 1315 Capital, a leading US Healthcare Private Equity Firm
• Expands NGI's private markets exposure in an attractive sector with scalable opportunity
• Partnership expected to create long-term value for NGI shareholders

Navigator Global Investments Limited (NGI) has announced that it has entered into an agreement to acquire a strategic 23.5% equity stake in 1315 Capital, LLC, and its affiliates ('1315 Capital'). 1315 Capital is a private equity firm with over USD 1.0 billion in assets under management that provides growth equity and growth buyout capital to commercial-stage medtech & pharma outsourcing, healthcare services, medical technology, and health & wellness companies. The transaction will see NGI acquire a minority interest in 1315 Capital, including a stake in certain carried interest, for a total maximum consideration of USD 70.5 million, of which USD 27.5 million is deferred and subject to performance criteria. The partnership is expected to broaden NGI's exposure in private markets and diversify its portfolio in an attractive sector with a scalable opportunity set. NGI's CEO, Stephen Darke, commented that the new partnership is the next important step in the company's strategy to partner with leading alternative investment firms globally, and will create long-term value for NGI shareholders. The transaction will have no impact on the day-to-day management or operations of 1315 Capital, and the firm's investment and decision-making processes will remain unchanged.